EUVIMEDEUVIMED entdecken
Crossref

Economic effect of harm with high-risk NSAID prescribing

Drug and Therapeutics Bulletin · 2026-04 · 64 (4) · 58-58

DOI: 10.1136/dtb.2026.000008 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug and Therapeutics Bulletin, online erschienen am 10.03.2026. Hauptthemen laut MEDLINE: Anti-Inflammatory Agents, Non-Steroidal, Practice Patterns, Physicians'. Die Arbeit nennt 2 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Overview of: Camacho EM, Penner LS, Taylor A, et al . Estimating the economic effect of harm associated with high risk prescribing of oral non-steroidal anti-inflammatory drugs in England: population based cohort and economic modelling study. BMJ 2024;386:e077880. doi:10.1136/bmj-2023–077880

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Inflammatory Agents, Non-SteroidalPractice Patterns, Physicians'HumansEnglandModels, Economic

Stichwörter der Autor:innen

Drug interactionsGastrointestinal diseases

Substanzen

Anti-Inflammatory Agents, Non-Steroidal

Zitieren

APA

(2026). Economic effect of harm with high-risk NSAID prescribing. Drug and Therapeutics Bulletin, 64(4), 58-58. https://doi.org/10.1136/dtb.2026.000008

Vancouver

Economic effect of harm with high-risk NSAID prescribing. Drug and Therapeutics Bulletin. 2026;64(4):58-58. doi:10.1136/dtb.2026.000008

BibTeX
@article{euvimed2026,
  title = {Economic effect of harm with high-risk NSAID prescribing},
  journal = {Drug and Therapeutics Bulletin},
  year = {2026},
  volume = {64},
  number = {4},
  pages = {58--58},
  doi = {10.1136/dtb.2026.000008}
}
Kostenlos starten →